The present invention relates generally to medical fluid-delivery devices, and more specifically to infusion pumps.
Pumps are often used in the medical industry for delivering fluids, e.g., drugs or diagnostic fluids, to subjects. One type of medical pump is an infusion pump, used to infuse a fluid into a subject's circulatory system via infusion tubing. Some infusion pumps include a valve, or system of valves, that may occlude flow within the infusion tubing by pressing on the outside of the fluid-filled infusion tubing. Often infusion pumps engage with the infusion tubing via tube cassette. A common safety feature of tube cassettes is an anti-free-flow valve that ensures that the infusion tubing is occluded in the event that the tube cassette is disengaged from the pump.
A tube cassette and infusion pump for delivering a fluid to a subject are provided, in accordance with some applications of the present invention. The tube cassette receives the infusion tubing and is removably couplable to the pump. The tube cassette comprises an anti-free-flow valve that occludes the infusion tubing and can be actuated by a force external to the tube cassette to terminate the occlusion. Thus, in the absence of the external force, i.e., in its rest-state, the anti-free-flow valve occludes the infusion tubing. The infusion pump, e.g., a volumetric infusion pump, or peristaltic infusion pump, delivers the fluid to the subject by repeatedly (a) pressing on the infusion tubing with a pressing surface so as to push fluid toward the subject and then (b) raising the pressing surface from pressing on the infusion tubing so as to intake more fluid from a fluid source. When the tube cassette is coupled to the pump, as part of a pumping cycle for delivering the fluid to the subject, the pump repeatedly (a) actuates the anti-free-flow valve to terminate the occlusion of the infusion tubing, and subsequently (b) releases the anti-free-flow valve, allowing it to return to its rest state and occlude the infusion tubing. Thus, the pump uses the anti-free-flow valve of the tube cassette to deliver the fluid from the fluid source to the subject.
For some applications, the tube cassette comprises a lever, the anti-free-flow valve being disposed on the load arm (further described hereinbelow) of the lever. The lever is spring-loaded so as to maintain the anti-free-flow valve occluding the infusion tubing. The anti-free-flow valve may be actuated to terminate the occlusion by a force applied to the effort arm (further described hereinbelow) of the lever, in opposition to the spring loading of the lever. The anti-free-flow valve may be manually actuated to terminate the occlusion by a user when the tube cassette is not coupled to the pump, e.g., by the user pressing on the effort arm of the lever in opposition of the spring loading. Additionally, the anti-free-flow valve may be actuated to terminate the occlusion by a force applied by the pump to the effort arm of the lever in opposition of the spring loading.
There is therefore provided, in accordance with some applications of the present invention, apparatus for delivering a fluid to a subject through infusion tubing, the apparatus including:
For some applications, the pump includes a pressing surface configured to press on the infusion tubing when the tube cassette is coupled to the pump.
For some applications, the anti-free-flow valve is configured to occlude the infusion tubing in the absence of any force external to the tube cassette being applied to the anti-free-flow valve.
For some applications, the anti-free-flow valve is configured to be actuated by the subject to terminate the occlusion of the infusion tubing when the tube-cassette is not coupled to the pump.
For some applications, a length of the tube cassette is 2-20 cm.
For some applications, the pump includes at least one pump-valve disposed within the pump and configured to occlude the infusion tubing when the tube cassette is coupled to the pump.
For some applications, the at least one pump-valve is exactly one pump-valve, and is the only valve disposed within the pump when the tube cassette is not coupled to the pump.
For some applications:
For some applications, the pump is configured to deliver the fluid to the subject by repeatedly, sequentially:
For some applications, the anti-free-flow valve is configured to be actuated to terminate the occlusion of the infusion tubing, upon the force external to the tube cassette being applied at a location along the infusion tubing longitudinally displaced from a site where the anti-free-flow valve occludes the infusion tubing.
For some applications, the tube cassette further includes a lever, the anti-free-flow valve being
For some applications, the anti-free-flow valve is configured to be actuated to terminate the occlusion of the infusion tubing by the external force having any of a range of values, the range of values including 50 N.
For some applications, the range of values includes 25 N.
For some applications, the range of values includes 1 N.
For some applications, the range of values includes 0.5 N.
There is further provided, in accordance with some applications of the present invention, apparatus for delivering a fluid to a subject through infusion tubing, the apparatus including:
There is further provided, in accordance with some applications of the present invention, apparatus for use with a pump and infusion tubing, the apparatus including:
For some applications, the anti-free-flow valve is configured to be actuated to terminate the occlusion of the infusion tubing by the force, applied manually or by the pump, having any of a range of values, the range of values including 50 N.
For some applications, the range of values includes 25 N.
For some applications, the range of values includes 1 N.
For some applications, the range of values includes 0.5 N.
The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
Reference is now made to
Typically, anti-free-flow valve 26 is actuated to terminate the occlusion of infusion tubing 22 upon the external force being applied at a location along the infusion tubing, represented by dashed line 28, that is longitudinally displaced from a site where anti-free-flow valve 26 occludes infusion tubing 22, represented by dashed line 30. For some applications, the longitudinal displacement of where the force is applied, e.g., of pressable actuator 32, from where the infusion tubing is occluded may be a distance D of at least 10 mm and/or less than 150 mm. Typically, tube cassette 20 comprises a pressable actuator 32 to which the external force used to actuate anti-free-flow valve 26 is applied. For example, when not coupled to pump 24, the subject may press on pressable actuator 32 in order to actuate anti-free-flow valve 26 to terminate the occlusion of infusion tubing 22.
For some applications, the longitudinal displacement of where the external force is applied, e.g., of pressable actuator 32, from the site where anti-free-flow valve 26 occludes infusion tubing 22, is achieved by tube cassette 20 comprising a lever 34. As is known in the field of mechanics, a first-class lever has a load arm and an effort arm positioned on either side of a fulcrum. Anti-free-flow valve 26 is disposed on, e.g., at the end of, a load arm 36 of lever 34 and pressable actuator 32 is disposed on, e.g., at the end of, an effort arm 38 of lever 34. A fulcrum 76 is disposed between load arm 36 and effort arm 38. Lever 34 is spring loaded, e.g., by a spring 40 positioned between a housing 42 of tube cassette 20 and pressable actuator 32, so as to maintain anti-free-flow valve 26 occluding infusion tubing 22. Anti-free-flow valve 26 is actuated to terminate the occlusion of infusion tubing 22 by the force external to tube cassette 20 being applied to effort arm 38 of lever 34, e.g., to pressable actuator 32 at the end of effort arm 38, in opposition to the spring loading.
Using a lever to displace (a) where the force is applied to actuate anti-free-flow valve 26 from (b) where the occlusion of infusion tubing 22 occurs, enables anti-free-flow valve 26 to be actuated to terminate the occlusion with relatively low force. For example, the force external to tube cassette 20 required to actuate anti-free-flow valve 26 can be as low as 1 N, e.g., 10 N, e.g., 20 N, e.g., 50 N, e.g., higher.
Reference is now made to
Typically, pump 24 is a volumetric pump that delivers the fluid to the subject by controlling two valves that occlude the infusion tube on either side of a pressing surface that presses on the infusion tube (as further described hereinbelow with reference to
Using anti-free-flow valve 26 as a valve that is part of the delivery cycle saves space within tube cassette 20, as it is no longer necessary for tube cassette 20 to be long enough to accommodate an anti-free-flow valve, an upstream valve of the pump and a downstream valve of the pump. Rather anti-free-flow valve 26 is used as either the upstream or the downstream valve during the pumping cycle. Typically, a length L of tube cassette 20 is at least 2 cm and/or less than 20 cm.
Reference is now made to
When anti-free-flow-valve-actuator 44 is moved, by pump 24, in an upward direction, represented by upward arrow 58 in
Reference is now made to
Subsequently, pump 24 actuates anti-free-flow-valve-actuator to press on pressable actuator 32, thereby terminating the occlusion of infusion tubing 22 downstream of pressing surface 46. Downward arrow 66 in
Subsequently, pump 24 actuates pressing surface 46 to press on infusion tubing 22 to push the fluid to the subject, represented by downward arrow 70 in
It is noted that in the configuration depicted, pump-valve 48 acts as the upstream valve, and anti-free-flow valve 26 acts as the downstream valve. This, however, is non-limiting, and it is within the scope of the present invention for pump-valve 48 to be positioned as the downstream valve and anti-free-flow valve 26 to be positioned as the upstream valve when tube cassette 20 is coupled to pump 24.
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application is the US national stage application of PCT/IL2020/050249, filed Mar. 4, 2020, which published as PCT Publication WO 2020/178827 to Shoham, and which claims the priority of U.S. 62/814,053 to Shoham, filed Mar. 5, 2019 entitled, “Anti-free-flow valve,” which is incorporated herein by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IL2020/050249 | 3/4/2020 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2020/178827 | 9/10/2020 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3379950 | Friedline | Apr 1968 | A |
4236880 | Archibald | Dec 1980 | A |
4322668 | Trussler et al. | Mar 1982 | A |
4391600 | Archibald | Jul 1983 | A |
4650469 | Berg et al. | Mar 1987 | A |
5018945 | D'Silva | May 1991 | A |
5049047 | Polaschegg et al. | Sep 1991 | A |
5096385 | Georgi et al. | Mar 1992 | A |
5116203 | Natwick et al. | May 1992 | A |
5340951 | Hungerbuhler et al. | Aug 1994 | A |
5437642 | Thill et al. | Aug 1995 | A |
5567119 | Johnson | Oct 1996 | A |
5807075 | Jacobsen et al. | Sep 1998 | A |
5807322 | Lindsey et al. | Sep 1998 | A |
5843035 | Bowman et al. | Dec 1998 | A |
5954485 | Johnson et al. | Sep 1999 | A |
6312227 | Davis | Nov 2001 | B1 |
6494864 | Kerwin et al. | Dec 2002 | B1 |
6523414 | Malmstrom et al. | Feb 2003 | B1 |
6531708 | Malmstrom et al. | Mar 2003 | B1 |
6554806 | Butterfield et al. | Apr 2003 | B2 |
6659976 | Beck et al. | Dec 2003 | B2 |
6679862 | Diaz et al. | Jan 2004 | B2 |
6702779 | Connelly et al. | Mar 2004 | B2 |
6750468 | Malmstrom et al. | Jun 2004 | B2 |
6852094 | Beck et al. | Feb 2005 | B2 |
6889556 | Steger | May 2005 | B2 |
6907788 | Malmstrom et al. | Jun 2005 | B2 |
6908452 | Diaz et al. | Jun 2005 | B2 |
6979311 | Miles et al. | Dec 2005 | B2 |
7048715 | Diaz et al. | May 2006 | B2 |
7059840 | Corwin et al. | Jun 2006 | B2 |
7070575 | Beck et al. | Jul 2006 | B2 |
7092796 | Vanderveen | Aug 2006 | B2 |
7121143 | Malmstrom et al. | Oct 2006 | B2 |
7163381 | Barak | Jan 2007 | B1 |
7356382 | Vanderveen | Apr 2008 | B2 |
7384408 | Barak | Jun 2008 | B2 |
7497842 | Diaz et al. | Mar 2009 | B2 |
7695448 | Cassidy et al. | Apr 2010 | B2 |
7726174 | Riley et al. | Jun 2010 | B2 |
7758551 | Wiesner et al. | Jul 2010 | B2 |
7819838 | Ziegler et al. | Oct 2010 | B2 |
7875004 | Yodfat et al. | Jan 2011 | B2 |
7881883 | Remde | Feb 2011 | B2 |
7892199 | Mhatre et al. | Feb 2011 | B2 |
7896197 | Furey et al. | Mar 2011 | B2 |
7921718 | Malmstrom et al. | Apr 2011 | B2 |
7922700 | Evans et al. | Apr 2011 | B2 |
7967773 | Amborn et al. | Jun 2011 | B2 |
7981082 | Wang et al. | Jul 2011 | B2 |
8025654 | Barak | Sep 2011 | B2 |
8034020 | Dewey | Oct 2011 | B2 |
8048022 | Moy et al. | Nov 2011 | B2 |
8081069 | Haueter et al. | Dec 2011 | B2 |
8105269 | Zhou | Jan 2012 | B2 |
8142400 | Rotem et al. | Mar 2012 | B2 |
8152780 | Evans et al. | Apr 2012 | B2 |
8167832 | Bowman et al. | May 2012 | B2 |
8182461 | Pope et al. | May 2012 | B2 |
8197235 | Davis | Jun 2012 | B2 |
8225639 | Riley et al. | Jul 2012 | B2 |
8232484 | Hauck | Jul 2012 | B2 |
8286505 | Wade | Oct 2012 | B2 |
8287495 | Michaud et al. | Oct 2012 | B2 |
8298184 | Diperna et al. | Oct 2012 | B2 |
8328786 | Strickler et al. | Dec 2012 | B2 |
8343111 | Beck et al. | Jan 2013 | B2 |
8361021 | Wang et al. | Jan 2013 | B2 |
8378837 | Wang et al. | Feb 2013 | B2 |
8394051 | Geipel | Mar 2013 | B2 |
8419676 | Evans et al. | Apr 2013 | B2 |
8448523 | Richter | May 2013 | B2 |
8486005 | Yodfat et al. | Jul 2013 | B2 |
8486020 | Hills et al. | Jul 2013 | B2 |
8496613 | Zhou | Jul 2013 | B2 |
8539672 | Eggers et al. | Sep 2013 | B2 |
8567235 | Bojan et al. | Oct 2013 | B2 |
8641671 | Michaud et al. | Feb 2014 | B2 |
8657778 | Ziegler et al. | Feb 2014 | B2 |
8690014 | Haueter et al. | Apr 2014 | B2 |
8690860 | Abal | Apr 2014 | B2 |
8733178 | Bivans et al. | May 2014 | B2 |
8752436 | Beck et al. | Jun 2014 | B2 |
8758323 | Michaud et al. | Jun 2014 | B2 |
8771227 | Connelly et al. | Jul 2014 | B2 |
8795225 | Lewis et al. | Aug 2014 | B2 |
8808230 | Rotstein | Aug 2014 | B2 |
8821432 | Unverdorben | Sep 2014 | B2 |
8852141 | Mhatre et al. | Oct 2014 | B2 |
8859972 | Cummings et al. | Oct 2014 | B2 |
8876787 | Beck et al. | Nov 2014 | B2 |
8900213 | Pope et al. | Dec 2014 | B2 |
8926561 | Verhoef et al. | Jan 2015 | B2 |
8943894 | Geipel | Feb 2015 | B2 |
8945064 | Gravesen et al. | Feb 2015 | B2 |
8961453 | Bowman et al. | Feb 2015 | B2 |
8974415 | Robert et al. | Mar 2015 | B2 |
8986253 | Diperna | Mar 2015 | B2 |
9004886 | Beck et al. | Apr 2015 | B2 |
9005153 | Kopperschmidt et al. | Apr 2015 | B2 |
9017296 | Beck et al. | Apr 2015 | B2 |
9033923 | Hartman et al. | May 2015 | B2 |
9101712 | Denis et al. | Aug 2015 | B2 |
9109966 | Duits | Aug 2015 | B2 |
9132230 | Blomquist | Sep 2015 | B2 |
9162023 | Barnes et al. | Oct 2015 | B2 |
9173998 | Rosinko et al. | Nov 2015 | B2 |
9211377 | Diperna et al. | Dec 2015 | B2 |
9227008 | Magnenat et al. | Jan 2016 | B2 |
9234850 | Hammond et al. | Jan 2016 | B2 |
9248230 | Geipel et al. | Feb 2016 | B2 |
9272087 | Halbert et al. | Mar 2016 | B2 |
9285324 | Leuenberger Jockel | Mar 2016 | B2 |
9308323 | Adams | Apr 2016 | B2 |
9375531 | Lee et al. | Jun 2016 | B1 |
9408968 | Browne et al. | Aug 2016 | B2 |
9415158 | Miller et al. | Aug 2016 | B2 |
9427521 | Pope et al. | Aug 2016 | B2 |
9468713 | Hoenninger, III et al. | Oct 2016 | B2 |
9474854 | Mhatre et al. | Oct 2016 | B2 |
9480793 | Mhatre et al. | Nov 2016 | B2 |
9480794 | Keith et al. | Nov 2016 | B2 |
9545478 | Abal | Jan 2017 | B2 |
9561323 | Plahey et al. | Feb 2017 | B2 |
9603998 | Geipel et al. | Mar 2017 | B2 |
9610404 | Rotstein | Apr 2017 | B2 |
9642777 | Lewis et al. | May 2017 | B2 |
9662437 | Moosai | May 2017 | B2 |
9675756 | Kamen et al. | Jun 2017 | B2 |
9677555 | Kamen et al. | Jun 2017 | B2 |
9682192 | Marsh et al. | Jun 2017 | B2 |
9683562 | Davis et al. | Jun 2017 | B2 |
9717849 | Mhatre et al. | Aug 2017 | B2 |
9757517 | Eberhard | Sep 2017 | B2 |
9770552 | Hartman et al. | Sep 2017 | B2 |
9775947 | Keith et al. | Oct 2017 | B2 |
9789251 | Robert et al. | Oct 2017 | B2 |
9839744 | Muto et al. | Dec 2017 | B2 |
9879668 | Yavorsky et al. | Jan 2018 | B2 |
9901676 | Mijers et al. | Feb 2018 | B2 |
9932977 | Bresina et al. | Apr 2018 | B2 |
9937290 | Connelly et al. | Apr 2018 | B2 |
9937291 | Eberhard | Apr 2018 | B2 |
9958344 | Burkhard | May 2018 | B2 |
9962486 | Rosinko et al. | May 2018 | B2 |
9987424 | Kim | Jun 2018 | B2 |
9995642 | Shimoyama et al. | Jun 2018 | B2 |
10004847 | Wander et al. | Jun 2018 | B2 |
10006453 | Girard et al. | Jun 2018 | B2 |
10022494 | Shimizu | Jul 2018 | B2 |
10022495 | Halbert et al. | Jul 2018 | B2 |
10022496 | Geipel et al. | Jul 2018 | B2 |
10046112 | Oruklu et al. | Aug 2018 | B2 |
10080836 | Juretich et al. | Sep 2018 | B2 |
10092697 | Nessel et al. | Oct 2018 | B2 |
10112009 | Dudar et al. | Oct 2018 | B2 |
10151646 | Heo et al. | Dec 2018 | B2 |
10539453 | Hauck | Jan 2020 | B2 |
11213460 | O'Keefe et al. | Jan 2022 | B2 |
20030141468 | Malmstrom et al. | Jul 2003 | A1 |
20050107923 | Vanderveen | May 2005 | A1 |
20060173412 | Susi | Aug 2006 | A1 |
20060189926 | Hall et al. | Aug 2006 | A1 |
20060206054 | Shekalim | Sep 2006 | A1 |
20070123781 | Callahan et al. | May 2007 | A1 |
20070179435 | Braig et al. | Aug 2007 | A1 |
20080283296 | Zamora et al. | Nov 2008 | A1 |
20090221964 | Rotem et al. | Sep 2009 | A1 |
20090240201 | Rotem et al. | Sep 2009 | A1 |
20090293588 | Riley et al. | Dec 2009 | A1 |
20100106082 | Zhou | Apr 2010 | A1 |
20100114001 | O'Mahony | May 2010 | A1 |
20100212407 | Stringham et al. | Aug 2010 | A1 |
20100280446 | Kalpin | Nov 2010 | A1 |
20110087165 | Amborn et al. | Apr 2011 | A1 |
20110152772 | Rotem et al. | Jun 2011 | A1 |
20110190606 | Gable et al. | Aug 2011 | A1 |
20120205312 | Hogard | Aug 2012 | A1 |
20120238949 | Kalpin | Sep 2012 | A1 |
20120330574 | Ruiter et al. | Dec 2012 | A1 |
20130035659 | Hungerford et al. | Feb 2013 | A1 |
20130226129 | Unverdorben | Aug 2013 | A1 |
20130336814 | Kamen et al. | Dec 2013 | A1 |
20140066850 | Robert et al. | Mar 2014 | A1 |
20140119954 | Schweitzer et al. | May 2014 | A1 |
20140121639 | Lowery et al. | May 2014 | A1 |
20140228755 | Darrah et al. | Aug 2014 | A1 |
20150238689 | Shimizu | Aug 2015 | A1 |
20150367120 | Kusters et al. | Dec 2015 | A1 |
20180140770 | Hetchler et al. | May 2018 | A1 |
20180200456 | Eitan et al. | Jul 2018 | A1 |
20180318505 | Eitan et al. | Nov 2018 | A1 |
20200085695 | O'Keefe et al. | Mar 2020 | A1 |
20200282138 | Eitan et al. | Sep 2020 | A1 |
20210178062 | Eitan | Jun 2021 | A1 |
20210212903 | O'Keefe et al. | Jul 2021 | A1 |
20210353507 | O'Keefe et al. | Nov 2021 | A1 |
Number | Date | Country |
---|---|---|
103727021 | Apr 2014 | CN |
0182502 | May 1986 | EP |
1381843 | Mar 2009 | EP |
2040056 | Sep 2010 | EP |
1381889 | Mar 2016 | EP |
2570826 | Aug 2016 | EP |
3834862 | Jun 2021 | EP |
2553151 | Apr 1985 | FR |
2150644 | Jul 1985 | GB |
WO-9421918 | Sep 1994 | WO |
02068018 | Sep 2002 | WO |
2012126744 | Sep 2012 | WO |
2019155453 | Aug 2019 | WO |
2020060996 | Mar 2020 | WO |
2020178824 | Sep 2020 | WO |
2021146374 | Jul 2021 | WO |
Entry |
---|
An Office Action dated Sep. 30, 2019, which issued during the prosecution of U.S. Appl. No. 15/740,365. |
European Search Report dated Jun. 21, 2019 which issued during the prosecution of European Application No. 16817348.2. |
An International Search Report and a Written Opinion both dated Aug. 5, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050409. |
An Office Action dated Jun. 22, 2020, which issued during the prosecution of U.S. Appl. No. 15/740,365. |
European Search Report dated Jun. 4, 2020, which issued during the prosecution of Applicant's European App No. 20160966.6. |
An International Search Report and a Written Opinion both dated Jun. 9, 2020, which issued during the prosecution of Applicant's PCT/IL2020/050246. |
European Search Report dated May 12, 2021 which issued during the prosecution of Applicant's European App No. 20212979.7. |
U.S. Appl. No. 62/814,053, filed Mar. 5, 2019. |
European Search Report dated Oct. 8, 2021 which issued during the prosecution of Applicant's European App No. 18905766.4. |
Notice of Allowance dated Aug. 4, 2021, which issued during the prosecution of U.S. Appl. No. 16/808,652. |
An International Search Report and a Written Opinion both dated May 15, 2020, which issued during the prosecution of Applicant's PCT/IL2020/050249. |
Number | Date | Country | |
---|---|---|---|
20220040405 A1 | Feb 2022 | US |
Number | Date | Country | |
---|---|---|---|
62814053 | Mar 2019 | US |